Member Info for mact4

Not had a chance to read today's forum yet - but here's where I'm at.

Yesterday's price action was an inside bar. It looked like 157ish was the last low; the triangle pattern still looks feasible as PA has not broken below the trendline. Decided to back myself and grabbed a few at 167.

If the triangle pattern holds true, next stop circa 217 before a retrace to 170 region, followed by a bounce back up. If price breaks below 157, triangle pattern no longer holds.

Don’t forget licensing deals. Synairgen’s income is not limited to just what it can produce, the greater value comes from owning that patent.

Ah, thanks for explaining Welsh. I see a figure for my share allocation but the 'unit price paid' is still blank. You have cleared this up nicely.

I'm with HL and I got the extra I asked for.

Okay - sticking my neck out here.
If SP holds above 156, we may be looking at a triangle pattern for wave 4. If so, price could reach circa 217 before dropping back to circa 170 and then a break out of this triangle.
Be interesting to see if I am brave enough to follow through on my own price analysis. Called 150 before but did not dare act ...

I agree, Goose. But it's still painful if you were not fortunate enough to hear about SYN before Manic Monday. But I'm holding ;-)

Goose:
Merely your everyday trading psychology: fear vs greed. When SP slips, fear takes over, and vice-versa.

Seriously, Richar? Can you not accept a different opinion?

136 is simply the last low. Simple technicals. I am hoping the price does not go below 157 but I am bracing myself should it go lower.

If SP does not stay above 157, next level could be 136.

Each picture sold will go towards funding a test patient ;-)

https://www.facebook.com/watch/?v=1322038528136509

Just bracing myself. I fear we might see SP of £1.57 - though hopefully will not linger long at this level.

So ... they basically switched their system off and on again? Highly technical method.

Shaking the branch? Panicking PIs?

Are you all experiencing frequent downtimes with LSE chat service?

@Matml. I’m happy to acknowledge if I’m wrong but the specific trial for Covid19 was circa 100, wasn’t it?

Thanks again pmjh.

RM is confident and we are confident about Synairgen - but at the end of the day, scientists crunch data and with a data set of 100, it is a limiting factor. Roll on phase 3. ASAP!

@ Jack

Ouch!!

Jack, it’s a generational thing. You’ve probably never seen or held a floppy disk ????

So this is what I understand so far:
a JV partner will bring added value to the company by bringing Synteferon to the masses; company stays in current hands

However, there is nothing to prevent a TO, friendly or hostile, at a later stage as this will be determined by a majority holding.

No?